Dr Reddy's and Nestle Health Science strengthen presence in diabetes, obesity nutrition space
Business 07 May, 2026

Dr Reddy's and Nestle Health Science strengthen presence in diabetes, obesity nutrition space

Business To Business, New Delhi, 7th May, 2026: Dr. Reddy’s Laboratories and Nestlé Health Science on Thursday announced the launch of ‘Celevida GLP+’, strengthening their presence in the diabetes and obesity nutrition segment.
The joint venture between Dr Reddy’s Laboratories and Nestlé India said the product has been scientifically designed to support optimal nutrition intake and muscle mass maintenance for people undergoing GLP-1/GIP therapy for the management of Type 2 Diabetes and obesity in India.
“GLP-1 therapies represent a significant advancement in diabetes and obesity management. However, a clear unmet need remains in supporting patients beyond pharmacological treatment, particularly in addressing nutrition gaps and preserving muscle health during therapy,” said M V Ramana.

Related News